S. B. Hanauer

Statistics

Publications

Citations

3.5K

H-Index

Active since

1981

Affiliations

University of Chicago(Current)

University of California San Diego

University of Calgary

Mayo Clinic

Atlanta Gastroenterology Associates

S. B. Hanauer is an author at University of Chicago specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and pharmacotherapy.

Publications per year

1981–2016

Publications

Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial

William J. Sandborn, S. B. Hanauer, P. Rutgeerts et al. · Gut · 2007 · 1K citations · Full text

Medicine, Clinical Sciences, Pharmacology +16

Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial

William J. Sandborn, S. B. Hanauer, Seymour Katz et al. · Gastroenterology · 2001 · 911 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial

Eli D. Ehrenpreis, Sunanda V. Kane, Lawrence B. Cohen et al. · Gastroenterology · 1999 · 331 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +11

An engineered human antibody to TNF (CDP571) for active Crohn's disease: A randomized double-blind placebo-controlled trial

William J. Sandborn, Brian G. Feagan, S. B. Hanauer et al. · Gastroenterology · 2001 · 254 citations · Full text

Veterinary Medicine, Clinical Sciences, Immunology +16

Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease - subgroup results from a placebo-controlled study

Stefan Schreiber, Ian C. Lawrance, Ole Østergaard Thomsen et al. · Alimentary Pharmacology & Therapeutics · 2010 · 162 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

1–5 of 21